The dvm360® cardiology page is home to a plethora of resources involving the latest advancements in diagnosing, managing, and treating cardiology. From expert insights into the latest trends to interviews, videos, podcasts, news, and beyond, find out everything you need to know about cardiology here.
November 22nd 2024
Vetmedin Solution from Boehringer Ingelheim is indicated for treatment of cases caused by myxomatous mitral valve disease or dilated cardiomyopathy and is the first oral solution approved by the FDA for this use in dogs
October 26th 2024
Pericardial effusion: causes and clinical outcomes in dogs (Proceedings)
August 1st 2011Pericardial effusion is a fairly common acquired heart disease in dogs, and prevalence has been reported to be 0.43% (or 1 dog per 233 cases) of dogs presenting to a referral veterinary hospital, and accounts for approximately 7% of dogs with clinical signs of cardiac disease.1
Working up pleural effusions in cats (Proceedings)
August 1st 2011Cats presenting with pleural effusion are nearly always in respiratory distress, ranging from an increased respiratory rate and effort to open mouth breathing. In the latter situations, therapeutic intervention must be initiated quickly to prevent respiratory arrest. The therapeutic intervention also provides your first diagnostic test.
Thromboembolic disease (Proceedings)
August 1st 2011Thrombophilia (hypercoagulability or prothrombotic state) is a complex disorder with a diverse and multifactorial pathogenesis that results in a wide spectrum of clinical manifestations. It is well-recognized as a frequent and serious cause of morbidity and mortality in people. It appears less prevalent in dogs and cats for several reasons.
Heartworms in cats: new insights (Proceedings)
August 1st 2011A new study performed at Auburn University's College of Veterinary Medicine is radically changing our understanding of how heartworms affect the cat. In this study three groups of cats were studied for 8 and 16 months with antibody and antigen tests, radiographs of the heart and lungs, and necropsy examinations of the heart and lungs.
The silent killer: pulmonary hypertension (Proceedings)
August 1st 2011Pulmonary hypertension (PH) is defined by a systolic pulmonary artery pressure greater than 25 mmHg. The incidence of PH is difficult to define due to lack of clinical awareness, non-specific clinical signs, and difficulty in confirming the diagnosis.
Dyspneic cats: triage and differentiation of cardiogenic versus noncardiogenic causes (Proceedings)
August 1st 2011Respiratory abnormalities are relatively common in cats, who may suffer from a wide range of disease processes. An initial triage step in the management of a dyspnic cat is to determine whether the dyspnea is cardiogenic or due to extracardiac (primary pulmonary) disease. This task is in no way a simple one, as cats often have non-specific history and physical examination abnormalities.
Essentials of echocardiography (Proceedings)
August 1st 2011Echocardiography has emerged as the most valuable non-invasive tool for evaluation of cardiac structure, function, blood flow patterns, and has greatly diminished the need for diagnostic cardiac catheterizations and angiocardiography in many cases. Echocardiography is one tool for evaluation of the cardiac patient, but should be used in conjunction with other diagnostic tests including thoracic radiography and electrocardiography for a global assessment of the patient.
Back to basics: clinical cardiovascular exam and diagnostic testing (Proceedings)
August 1st 2011Although there are highly sophisticated and advanced diagnostic modalities in cardiology, the basic technique of a good cardiovascular examination is still an essential fundamental element of the cardiovascular workup. Other basic diagnostic modalities that are readily available in most practices include thoracic radiographs, electrocardiography, and blood pressure measurement.
Managing Heart Disease and Heart Failure in Your Feline Patients (Sponsored by IDEXX)
July 6th 2011This online on-demand archived Webinar will highlight the importance of differentiating between heart disease and heart failure and will discuss the impact on diagnosis, therapy and monitoring your feline patients. (1 CE credit)
Don't Miss a Beat: What You Need to Know About Canine and Feline Heart Disease (Sponsored by IDEXX)
July 6th 2011This online on-demand archived Webinar will introduce you to a classification scheme for heart disease and heart failure and will discuss the clinical significance of signalment, history and common cardiac diagnostic tests to appropriately stage dogs and cats with heart disease. (1 CE credit)
The nuts and bolts of blood pressure measurement (Proceedings)
May 1st 2011Blood pressure measurement is often not a routine part of small animal practice. This partially has to do with the equipment available to measure blood pressure as well as our patients (they tend not to hold still like we have to).
Feline cardiovascular diseases: parts 1, 2, 3 (Proceedings)
May 1st 2011Cardiovascular (CV) diseases in cats include congenital malformations, acquired heart, and vascular disorders. Myocardial disorders or cardiomyopathies, the major cause of heart failure, thromboembolism, and persistent arrhythmias in cats, constitute the focus of this presentation.
ECG reading session-cardiac arrhythmias (Proceedings)
May 1st 2011Arrhythmias can be classified based on ECG analysis based on the heart rate (normal, bradyarrhythmias, tachyarrhythmias); anatomic origin of the rhythm disturbance (SA, atrial, atrioventricular, or ventricular); or electrophysiologic mechanism when evident.
Management of acquired canine heart disease: part 1 & 2 (Proceedings)
May 1st 2011Acquired heart diseases of dogs include chronic degenerative valvular diseases (endocardiosis), pericardial diseases, cardiac neoplasia, dilated cardiomyopathy (DCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), pulmonary hypertension (PH), infective endocarditis, and heart rhythm disturbances, some of which represent primary electrical disorders and others that develop secondary to cardiac remodeling.
Management of heart failure (Proceedings)
May 1st 2011The technician should appreciate the definition and causes of CHF, as well as methods of evaluation. The drugs used to treat CHF should be understood, as well as related side-effects. This awareness improves both patient care and client communications.
Anesthesia for the cardiac patient (Proceedings)
November 1st 2010Anesthetizing a patient with cardiac disease requires a plan for the use of supportive measures to maintain adequate tissue perfusion. As in the case of left sided cardiac dysfunction patients, volume administration frequently is not an option to support blood pressure. In these cases, should a positive inotropic or pressor agent be indicated, the volume of the adjunctive agent required should be deducted from the volume of crystalloid administered to maintain a balanced hourly rate.